Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.
Aspen Pharmacare Manufacturing Dispute Shrouded in Mystery
Original Article by Kabelo Khumalo | Business Day | 23 April 2025
Explore the Aspen Pharmacare manufacturing dispute and its potential impact on core earnings for the 2025 financial year.
More Posts
Dis-Chem succession enters a new phase
The Dis-Chem succession is pivotal as founder Ivan Saltzman resigns from formal roles. Learn about the changes happening now.
Read more...
Ectopic pregnancy deaths expose care gaps
Ectopic pregnancy deaths remain preventable in South Africa as delayed diagnosis and treatment expose gaps in district care.
Read more...
Childhood immunisation coverage falls sharply in SA
Childhood immunisation coverage is falling sharply in SA as measles and other diseases spread. See why health officials are concerned.
Read more...